Bristol-Myers Squibb Plans to Build Biologics Facility in the U.S. (PR Newswire via Yahoo! Finance)
Bristol-Myers Squibb Company said today that it will build its new biologics facility in the United States. At its regularly scheduled meeting on March 7, the company's Board of Directors approved a capital expenditure in the amount of $660 million for the construction of a large-scale multi-product bulk biologics manufacturing facility.